Post Tagged with: "TSX Venture Exchange"

T-Bird Pharma Inc. Announces Name Change to Emerald Health Therapeutics Inc.

T-Bird Pharma Inc. Announces Name Change to Emerald Health Therapeutics Inc.

T-Bird Pharma Inc. (TSXV:TPI) (“T-Bird” or the “Company”), a licensed producer to cultivate and sell marijuana under the Marihuana for Medical Purposes Regulations (Canada), is pleased to announce that the Company has changed its name to “Emerald Health Therapeutics Inc.”, as approved by the board of directors of the Company and the TSX Venture Exchange. Effective June 23, 2015, the […]

August 20, 2015 · 0 comments · Feature Article
Bedrocan Announces Grant of Stock Options

Bedrocan Announces Grant of Stock Options

Bedrocan Cannabis Corp. (TSXV: BED) (“the Company” or “Bedrocan Canada”) announced today that it has granted 200,000 stock options to a director of the Company, each such stock option entitling the holder thereof to acquire one common share of the Company at an exercise price of $0.79 based on today’s closing share price. The options were issued with a term […]

July 16, 2015 · 0 comments · Feature Article
OrganiGram Announces License Renewal

OrganiGram Announces License Renewal

OrganiGram Holdings Inc. (TSX VENTURE:OGI) (OGRMF) (the “Company“) is pleased to announce that it has received an annual renewal of its license to cultivate and sell marijuana under the Marihuana for Medical Purposes Regulations (MMPR). “The team at Organigram has worked diligently to ensure that the Company has continued to meet the standards set by the industry’s regulatory bodies and […]

May 17, 2015 · 0 comments · Feature Article
OrganiGram Announces Increased Production and Patient Growth

OrganiGram Announces Increased Production and Patient Growth

OrganiGram Holdings Inc. (TSX VENTURE:OGI)(OGRMF) (the “Company“) is pleased to announce that is has successfully completed an initial harvest from one of the three newly constructed grow rooms that were approved by Health Canada in December 2014. As a result, the Company has significantly increased production, available strains, and has been able to increase its registered patient list by 250%. […]

April 2, 2015 · 0 comments · Feature Article
Bedrocan Initiates Domestic Production Operations

Bedrocan Initiates Domestic Production Operations

Bedrocan Cannabis Corp. (BED.V) (“Bedrocan” or the “Company”) announced that its recently licensed domestic production facility in the Greater Toronto Area is now operational. Live plant material consisting of genetic clones of Bedrocan’s proprietary strains of medicinal cannabis, has been successfully imported from the Company’s Dutch partner Bedrocan BV, and is now growing in the new facility’s specially-designed grow rooms. […]

March 25, 2015 · 0 comments · Feature Article
T-Bird Pharma Inc. Announces Partnership with Medna Biosciences Inc.

T-Bird Pharma Inc. Announces Partnership with Medna Biosciences Inc.

T-Bird Pharma Inc. (TSXV:TPI) (“T-Bird” or the “Company”), a pharmaceutical company focused on developing premium quality medical marijuana products and a licensed producer (“LP”) to cultivate marijuana under the Marihuana for Medical Purposes Regulations (Canada) (“MMPR”), is pleased to announce that it, together with certain of its shareholders, has entered into an agreement with Medna Biosciences Inc. (“Medna”) whereby Medna […]

March 17, 2015 · 0 comments · Feature Article
OrganiGram Obtains $2.5M Loan From Farm Credit Canada

OrganiGram Obtains $2.5M Loan From Farm Credit Canada

OrganiGram Holdings Inc. (TSX-V: OGI) (OTC US:OGRMF) (the “Company”) is pleased to announce that it has completed the purchase of its current facility as well as the adjoining building and land. The Company has secured a loan from Farm Credit Canada (“FCC”) in the amount of $2.5M, which has been used to finance 100% of the purchase costs. The purchase […]

March 16, 2015 · 0 comments · Feature Article
Bedrocan Announces Lease Extension And $2 Million Production Facility Loan

Bedrocan Announces Lease Extension And $2 Million Production Facility Loan

Bedrocan Cannabis Corp. (BED.V) (the “Company“) is pleased to announce that it has agreed with the landlord (the “Landlord“) of its 52,000 square foot production facility to extend the previous five-year term of its existing operating lease to a total of ten years, ending on August 31, 2024 (subject to increase based on the rate of inflation for years six […]

February 16, 2015 · 0 comments · Feature Article
Tweed Marijuana Inc. Finalizes Mortgage Funding For Tweed Farms

Tweed Marijuana Inc. Finalizes Mortgage Funding For Tweed Farms

Tweed Marijuana Inc. (Tweed) has obtained a mortgage on Tweed Farms Inc., the recently acquired greenhouse facility and surrounding property located at 453 Concession #5 Rd, Niagara-on-the-Lake, Ont. The mortgage was entered into with a leading Canadian financial institution. The terms and funding, finalized on Nov. 7, are as follows: $1,875,000, 25-year amortization, with a five-year fixed annual interest rate […]

December 3, 2014 · 0 comments · Feature Article
Dr. Bin Huang Appointed By T-bird Pharma Inc. As President, Chief Operating Officer And Director

Dr. Bin Huang Appointed By T-bird Pharma Inc. As President, Chief Operating Officer And Director

The principal activities of Thunderbird Biomedical Inc. are the production of marijuana from its Victoria, British Columbia production facility, as regulated by the Marihuana for Medical Purposes Regulations (Canada). Thunderbird obtained a medical marijuana license to undertake the production of medical marijuana in February 2014, being the fifth company in Canada to obtain such a license. Thunderbird was acquired by T-Bird […]

December 2, 2014 · 0 comments · Feature Article